Evidence map›Paper›PMID 37601303›Full record

ArticleACG case reports journal2023

Fulminant Presentation of Budd-Chiari Syndrome Secondary to COVID-19 Infection.

Harshavardhan Sanekommu, Sobaan Taj, Catherine Kilada, Jayasree Ravilla, Claudia Ramirez, Paula Espinosa Gonzalez, Steven Imburgio, Anmol Johal, Xiu Sun, Pranav N Shah and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ACG case reports journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Harshavardhan SanekommuDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Sobaan TajDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Catherine KiladaSchool of Medicine, Saint George's University, West Indies, Grenada.
Jayasree RavillaDepartment of Medicine, Monmouth Medical Center, Avenue Long Branch, NJ.
Claudia RamirezDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Paula Espinosa GonzalezDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Steven ImburgioDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Anmol JohalDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Xiu SunDepartment of Pathology, Jersey Shore University Medical Center, Neptune City, NJ.
Pranav N ShahDepartment of Radiology, Jersey Shore University Medical Center, Neptune City, NJ.
Mohammad HossainDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
Jersey Shore University Medical Center · USMonmouth Medical Center · USSt. George's University · GD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Budd-Chiari syndrome (BCS) is a rare condition characterized by the obstruction of hepatic venous outflow. It is estimated to affect 1 in 100,000 people worldwide. In cases of new BCS, inherited and acquired hypercoagulability states must be evaluated. Coronavirus disease 2019 (COVID-19) can induce a hypercoagulable state because of its extensive inflammatory response, and while it has been reported to cause portal vein thrombosis, it rarely causes BCS. This article presents a case of a 22-year-old man who developed fulminant symptoms and was subsequently diagnosed with BCS and portal vein thrombosis secondary to COVID-19 infection, after ruling out other inherited and acquired causes of BCS. In addition, a literature review is provided to understand the presentation and management of such patients. Although most patients improve with medical management, this article emphasizes the consideration of liver transplant for patients who do not improve.

Indexed as

anticoagulationBudd-Chiari SyndromeCOVID 19portal vein thrombosis

Identifiers

PMID37601303
PMCPMC10435036
OpenAlexW4385955761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.